Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 234

Similar articles for PubMed (Select 16901284)

1.

Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon alpha-2b and ribavirin combination after liver transplantation.

Dumortier J, Ducos E, Scoazec JY, Chevallier P, Boillot O, Gagnieu MC.

J Viral Hepat. 2006 Aug;13(8):538-43.

PMID:
16901284
2.

Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination.

Dumortier J, Scoazec JY, Chevallier P, Boillot O.

J Hepatol. 2004 Apr;40(4):669-74.

PMID:
15030984
3.

Sensitivity to antiviral therapy may change after liver transplantation in patients with chronic hepatitis C virus infection.

Feliu A, Carrión JA, Massaguer A, Martínez-Bauer E, García-Retortillo M, González P, Costa J, Sánchez-Tapias JM, Forns X.

J Viral Hepat. 2006 Aug;13(8):544-51.

PMID:
16901285
4.
5.

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, Cohard M, Reynes M, Chevallier M, Ducerf C, Baulieux J, Geffner M, Albrecht JK, Bismuth H, Trepo C.

Gastroenterology. 2003 Mar;124(3):642-50.

PMID:
12612903
6.

Pegylated interferon alpha-2a and ribavirin combination therapy in HCV liver transplant recipients. Experience of 7 cases.

Iacob S, Gheorghe L, Hrehoret D, Becheanu G, Herlea V, Popescu I.

J Gastrointestin Liver Dis. 2008 Jun;17(2):165-72.

7.

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy.

Poynard T, Colombo M, Bruix J, Schiff E, Terg R, Flamm S, Moreno-Otero R, Carrilho F, Schmidt W, Berg T, McGarrity T, Heathcote EJ, Gonçales F, Diago M, Craxi A, Silva M, Bedossa P, Mukhopadhyay P, Griffel L, Burroughs M, Brass C, Albrecht J; Epic Study Group.

Gastroenterology. 2009 May;136(5):1618-28.e2. doi: 10.1053/j.gastro.2009.01.039. Epub 2009 Jan 22.

PMID:
19208349
8.

Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation.

Lodato F, Berardi S, Gramenzi A, Mazzella G, Lenzi M, Morelli MC, Tame MR, Piscaglia F, Andreone P; Bologna Liver Transplantation Group (BLTG), Ballardini G, Bernardi M, Bianchi FB, Biselli M, Bolondi L, Cescon M, Colecchia A, D'Errico A, Del Gaudio M, Ercolani G, Grazi GL, Grigioni W, Lorenzini S, Pinna AD, Ravaioli M, Roda E, Sama C, Vivarelli M.

Aliment Pharmacol Ther. 2008 Aug 15;28(4):450-7. doi: 10.1111/j.1365-2036.2008.03761.x. Epub 2008 Jun 11.

PMID:
18549463
9.

Peginterferon alpha-2b plus ribavirin with or without amantadine [correction of amantidine] for the treatment of non-responders to standard interferon and ribavirin.

Hasan F, Al-Khaldi J, Asker H, Al-Ajmi M, Owayed S, Varghese R, Siddique I, Al-Nakib B.

Antivir Ther. 2004 Aug;9(4):499-503.

PMID:
15456080
10.

Interferon alpha 2b and ribavirin for the treatment of recurrent hepatitis C after liver transplantation: cohort study of 38 patients.

Mukherjee S, Lyden E, McCashland TM, Schafer DF.

J Gastroenterol Hepatol. 2005 Feb;20(2):198-203.

PMID:
15683421
11.

Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.

Hanouneh IA, Miller C, Aucejo F, Lopez R, Quinn MK, Zein NN.

Liver Transpl. 2008 Jan;14(1):53-8.

12.

Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen.

Biselli M, Andreone P, Gramenzi A, Lorenzini S, Loggi E, Bonvicini F, Cursaro C, Bernardi M.

Dig Liver Dis. 2006 Jan;38(1):27-32. Epub 2005 Nov 28.

PMID:
16311084
13.

Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.

Firpi RJ, Abdelmalek MF, Soldevila-Pico C, Reed A, Hemming A, Howard R, Van Der Werf W, Lauwers G, Liu C, Crawford JM, Davis GL, Nelson DR.

Liver Transpl. 2002 Nov;8(11):1000-6.

14.

The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1.

Brandão C, Barone A, Carrilho F, Silva A, Patelli M, Caramori C, Focaccia R, Pereira L, Pedroso M, Tatsch F, Pessoa M; Pegasys Brazilian Study Group.

J Viral Hepat. 2006 Aug;13(8):552-9.

PMID:
16901286
15.

Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation.

Schmitz V, Kiessling A, Bahra M, Puhl G, Kahl A, Berg T, Neuhaus R, Neuhaus P, Neumann U.

Ann Transplant. 2007;12(3):22-7.

PMID:
18290566
16.

Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C.

Wirth S, Pieper-Boustani H, Lang T, Ballauff A, Kullmer U, Gerner P, Wintermeyer P, Jenke A.

Hepatology. 2005 May;41(5):1013-8.

PMID:
15793840
17.

Identification of novel defective HCV clones in liver transplant recipients with recurrent HCV infection.

Iwai A, Marusawa H, Takada Y, Egawa H, Ikeda K, Nabeshima M, Uemoto S, Chiba T.

J Viral Hepat. 2006 Aug;13(8):523-31.

PMID:
16901282
18.

Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopenia.

Hofer H, Gurguta C, Bergholz U, Steindl-Munda P, Ferenci P.

Wien Klin Wochenschr. 2006 Oct;118(19-20):595-600.

PMID:
17136334
19.

The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant.

Rendina M, Schena A, Castellaneta NM, Losito F, Amoruso AC, Stallone G, Schena FP, Di Leo A, Francavilla A.

J Hepatol. 2007 May;46(5):768-74. Epub 2007 Feb 5.

PMID:
17383045
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk